1.Identification of the core promoter of the pmel gene of Bashang long-tail chickens.
Xiaohui LIU ; Rongyan ZHOU ; Yongdong PENG ; Chuansheng ZHANG ; Lanhui LI ; Xianglong LI
Chinese Journal of Biotechnology 2018;34(11):1750-1759
To explore the activity of the pmel core promoter of Bashang long-tail chickens, we constructed dual-luciferase expression vectors and transiently transfected into DF1 cells with Lipofectamine 2000. We measured the luciferase activity with the dual-luciferase detection kit. The 1 268 bp fragment in 5-flanking region of the pmel gene in Bashang long-tail chickens was cloned. The region from -1 200 bp to +68 bp included 2 CpG islands and multiple transcription factor binding sites. We constructed 9 expression vectors with different promoter regions and a mutant vector of the core promoter region of the pmel gene of Bashang long-tail chickens. The core promoter region from -840 bp to +68 bp was identified in the pmel gene. The region from -590 to -525 bp negatively regulated the pmel gene during the transcription process. The -840--590 bp and -525--266 bp regions were positive regulatory regions. The polymorphic sites (-456, -435, -410, -374 and -341) had a significant effect on the promoter activity of the pmel gene.
Animals
;
Chickens
;
genetics
;
Cloning, Molecular
;
CpG Islands
;
Luciferases
;
Promoter Regions, Genetic
;
gp100 Melanoma Antigen
;
genetics
2.Study on effect of lentinan in enhancing anti-tumor action of dendritic cytoma vaccine and its mechanism.
Jun WANG ; Zhi-dong ZHOU ; Da-jing XIA
Chinese Journal of Integrated Traditional and Western Medicine 2007;27(1):60-64
OBJECTIVETo improve the anti-tumor effect of dendritic cytoma vaccine (DCV) for finding an effective anti-tumor biotherapy.
METHODSDC vaccine prepared by transfection of adenovirus mediated melanoma-associated antigen gene (gp100) into bone marrow-derived dendritic cell (DC) was used to study the immuno-therapeutic effect and the mechanism of lentinan (LNT) in different dosages, used alone or combined with gp100-DC for treatment of B16 melanoma bearing mice.
RESULTSAfter being treated with LNT combining gp100-DC, the growth of malignant melanoma was inhibited with the tumor-free survival in the experimental animals being 66.7%. The treatment could also significantly enhance the activity of cytotoxicity T lymphocyte (CTL) and natural killer (NK) cells, elevate the levels of interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) in splenocytes, and histological examination showed that a large amount of inflammatory cells infiltrated inside and around the tumor, and obvious necrosis of tumor cells was found.
CONCLUSIONBy combined use with LNT the anti-tumor immuno-reaction of DCV vaccine could be enhanced effectively.
Adjuvants, Immunologic ; pharmacology ; therapeutic use ; Animals ; Antineoplastic Agents, Phytogenic ; pharmacology ; therapeutic use ; Cancer Vaccines ; administration & dosage ; immunology ; Cell Line ; Cell Line, Tumor ; Combined Modality Therapy ; Dendritic Cells ; cytology ; immunology ; Female ; Humans ; Lentinan ; pharmacology ; therapeutic use ; Melanoma, Experimental ; immunology ; pathology ; therapy ; Membrane Glycoproteins ; genetics ; immunology ; Mice ; Mice, Inbred C57BL ; Random Allocation ; Shiitake Mushrooms ; chemistry ; Survival Analysis ; Transfection ; gp100 Melanoma Antigen